Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03661970
Other study ID # 2018-006
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date June 10, 2018
Est. completion date April 20, 2023

Study information

Verified date February 2024
Source Pacific Northwest University of Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary purpose of the research is to study how synthesized speech and non-speech percepts (sounds) are recognized in subjects with cochlear implants (CI) who are not getting functional speech recognition using existing speech to CI algorithms. By identifying a partial set of phonemes (units of speech) from this CI feedback, a new language could be developed.


Description:

A cochlear implant (CI) is a small, complex electronic device used by the profoundly deaf or severely hard-of-hearing. The CI has two main components: 1. The externally worn microphone, sound processor and transmitter system; 2. The implanted receiver and electrode system sending electrical currents to the inner ear; whereby the external and internal components are held together by a magnet. The CI does not restore normal hearing; however, it does provide a small representation of sounds in the environment and help him or her to understand speech. Due to the limited capacity of the CI, hearing is vastly different from normal hearing and it is difficult to really understand what they are hearing; hence, the varying outcomes of CI users. Most of the current research on cochlear implants (CI) aims to improve speech recognition for spoken English. However, patients who have a cochlear implant late in life-basically after childhood-have a very limited ability to learn speech. Late implant CI recipients do not distinguish speech sounds well, but it is not known if non-speech sounds can be differentiated, and if so, whether they can be used to create a functional language. Honeder et al studied the latest CI to determine the impact of a new audio processor on speech perception in noise. Overall, this new CI may improve hearing performance especially in difficult listening situations; however, due to inconsistencies in technical setups, speech processors, coding strategies, spatial conditions, spectral and temporal noise characteristics, speech testing paradigms, and subjects' ear they were unable to find significant improvements. Thus, demonstrating the challenge of understanding truly, what CI users hear and understand. Usher Syndrome is the most common inherited condition where children are born with moderate to profound hearing loss, depending on the type affecting. Usher syndrome affects approximately 4 to 17 per 100,000 people, and accounts for about 50 percent of all hereditary deaf-blindness cases. Usher's syndrome affects three to six percent of all children who are deaf and who are hard-of-hearing. Of the three types, types 1 and 2 are the most common and make up about 95% of the reported cases. Since genetic factors are the most commonly known etiology for Usher's Syndrome, it is very difficult to know what exactly the effected patient might hear or understand while using a CI. A systematic review by Nishio et al showed relatively good CI outcomes; however, there have only been limited studies conducted on patients with other gene mutations. Overall, CI patients report improvements in speech and quality of life. Unfortunately, the exact mechanisms of how and what Usher Syndrome CI users' process still requires further investigation. Despite the historical usage and various advancements in computer technology for CIs, the hearing world has yet to implement underutilized methodology and technology to further train, assess, and advance the capabilities of CIs. More importantly, simulation hearing labs providing a standardized, patient controlled environment with high-fidelity tracking and monitoring hearing simulations using a keyboard synthesizer (Cognate) attached to an external CI will allow for a more comprehensive evaluation of the CI users' hearing experience, assimilation, interpretation, and user controlled actions. Cognate is a simplified and more structured speech synthesizer. The synthesizer will generate the CI output, an acoustic output, and a visual display of the acoustic signals and CI output on the monitor and record the outputs of the synthesizer. Cognate would be an alternate 'English' encoding CI system that might be simpler to learn, and would translate written English, not spoken English. Cognate would translate text into percepts (sounds) that the subject would 'hear'. These percepts (sounds) would be equivalent in a sense to phonemes (letters). With a partial set of phonemes (English uses 45 for very computer sounding speech synthesis), a new language could be developed. The feasibility and data from this study will be used for future studies to evolve the Cognate encoding CI system, especially for Usher Syndrome patients.


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date April 20, 2023
Est. primary completion date April 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults who are at least 18 years of age - Must have normal visual acuity as evidenced by the ability to read and write notes to and from study staff when necessary - Must be fluent reading and writing English - No confounding or concomitant medical issues except for deafness - Must be able to understand and perform assigned tasks - Must be computer literate - Normal hearing OR adult with compatible cochlear implant (Cochlear Nucleus 24 series cochlear implants) Exclusion Criteria: - Incompatible Cochlear Implant device - Less than 18 years of age - Not able to speak, read, or write English - Adult with less than six month's experience with their CI

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognate Speech Synthesizer sound percepts
The cognate speech synthesizer will generate an acoustic output, as well as a visual display of the acoustic signals. The outputs on the monitor and the synthesizer will be recorded.

Locations

Country Name City State
United States Cadwell Industries Inc Kennewick Washington

Sponsors (2)

Lead Sponsor Collaborator
Pacific Northwest University of Health Sciences Cadwell Industries, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recognition of synthesized speech and non-speech percepts (sounds) Self reported detection and differentiation of sounds generated by the Cognate Speech Synthesizer. 60 minutes
See also
  Status Clinical Trial Phase
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Withdrawn NCT02890576 - Ambulatory Telemonitoring of People With Hearing Loss and Having a Cochlear Implant COCHLESURV
Completed NCT01256229 - Outcomes In Children With Developmental Delay And Deafness Phase 1
Recruiting NCT04795986 - First Clinical Evaluation of HEARO Robotic Cochlear Implantation Surgery in Austria
Recruiting NCT05867173 - Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces N/A
Completed NCT06104813 - Evaluation of Deaf Men's Knowledge About Sexual Health
Completed NCT04563884 - Validity of the French Version of Deafness Questionnaires for Children and Adolescents
Not yet recruiting NCT06088953 - EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER N/A
Completed NCT03980808 - American Sign Language-Accessible Diabetes Education N/A
Completed NCT03694340 - Optimization of Cochlear Implant MAP-parameters in Children N/A
Terminated NCT01959152 - Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode N/A
Completed NCT02539901 - Development of a Deaf Child With a Cochlear Implant. N/A
Withdrawn NCT00604474 - Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants N/A
Completed NCT00511381 - Genetic Testing in Detection of Late-Onset Hearing Loss N/A
Terminated NCT03867058 - Tradeoff Between Spatial and Temporal Resolution
Completed NCT01109576 - Workshops for Veterans With Vision and Hearing Loss Phase 0
Completed NCT01400178 - Cochlear Implants in Post-lingually Children: Results After 10 Years N/A
Completed NCT04106063 - A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children
Active, not recruiting NCT03352154 - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants N/A
Recruiting NCT04495660 - Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in fNIRS N/A